Cannara Biotech Dividends
LOVE Stock | CAD 0.74 0.04 5.71% |
Dividend Paid And Capex Coverage Ratio is expected to grow to 1.50 this year. Cannara Biotech's past performance could be the main factor of why investors trade Cannara Biotech stock today. Investors should clearly understand every aspect of the Cannara Biotech dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Cannara Biotech's dividend schedule and payout information. Cannara Biotech dividends can also provide a clue to the current valuation of Cannara Biotech.
Last Reported | Projected for Next Year | ||
Dividend Paid And Capex Coverage Ratio | 1.43 | 1.50 |
Cannara |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Cannara Biotech must own a stock before its ex-dividend date to receive its next dividend.